To subscribe to our optical e-newsletters and receive them via e-mail, click here.
Central serous chorioretinopathy afflicts working-age patients. While many can be observed, some will require intervention.
This therapeutic revolution has important implications for health policy, for physicians and most importantly, for patients.
On the anniversary of the consensus guidelines, a look at what evidence gathered over the decade has taught us.
How clinical electrophysiology can improve your diagnosis and management of posterior segment disease.
Pseudophakic CME remains a common cause of reduced vision after cataract surgery. A look at its causes and treatment.
Recognizing the distinctive features of each placoid disorder is critical for accurate and timely diagnosis and management.
This potentially visually devastating condition is most commonly associated with choroidal neovascularization due to AMD.
Clinicians face a complex algorithm when choosing an optimal anti-VEGF regimen. Here is what several recent studies found.
Reduction or maintenance of geographic atrophy lesion size in the retinal pigment epithelium has garnered increased attention.
The eye represents a unique target organ for gene therapy. Here’s a look at some of the current avenues of research.
Copyright© 2000 - 2014 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.